# An Integrated Clinical and Biomarker Model Using Penalized Regression to Predict In-Hospital Mortality in Acute Pulmonary Embolism

**Authors:** Corina Cinezan, Camelia Bianca Rus

PMC · DOI: 10.3390/jcm15031308 · Journal of Clinical Medicine · 2026-02-06

## TL;DR

This study develops a model combining clinical and biomarker data to predict in-hospital mortality in acute pulmonary embolism patients, showing better performance than existing tools.

## Contribution

The novel contribution is a penalized regression model integrating clinical and troponin biomarker data for improved mortality prediction in acute PE.

## Key findings

- The model retained four predictors: syncope, RV dysfunction, lower SBP, and higher troponin levels.
- The model showed an optimism-corrected AUC of 0.70 and strong calibration with a Brier score of 0.066.
- Decision-curve analysis indicated the model provided greater net benefit than existing strategies for triage.

## Abstract

Background: Early mortality risk stratification is essential in acute pulmonary embolism (PE). Integrating clinical variables with biomarkers may enhance prognostic accuracy beyond established tools. Methods: In a retrospective cohort of 322 patients with confirmed acute PE, we evaluated syncope, right-ventricular (RV) dysfunction, systolic blood pressure (SBP) and biochemical markers as candidate predictors of in-hospital mortality. A penalized logistic regression model using LASSO (least absolute shrinkage and selection operator) was developed and internally validated with five-fold cross-validation and 200 bootstrap repetitions. Discrimination, calibration and clinical utility were assessed using the area under the receiver operating characteristic curve (AUC), Brier score and decision-curve analysis (DCA). Results: In-hospital mortality was 5.6% (n = 18). LASSO retained four predictors: syncope, RV dysfunction, lower SBP and higher troponin levels. The optimism-corrected AUC was 0.70 (95% CI 0.63–0.77), with strong calibration (Brier score 0.066). DCA showed that the model provided greater net benefit than treat-all, treat-none, and sPESI strategies across threshold probabilities of approximately 7–25%, supporting its potential value for early triage. NT-proBNP, D-dimer and lactate did not add incremental predictive information after penalization. Conclusions: A simple, interpretable model integrating clinical parameters and troponin demonstrates good predictive performance and favorable clinical utility for early mortality risk estimation in acute PE. External validation is required before broader implementation.

## Linked entities

- **Diseases:** pulmonary embolism (MONDO:0005279)

## Full-text entities

- **Diseases:** RV dysfunction (MESH:D018497), syncope (MESH:D013575), Acute Pulmonary Embolism (MESH:D011655), Mortality (MESH:D003643)
- **Chemicals:** lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12897663/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12897663/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12897663/full.md

---
Source: https://tomesphere.com/paper/PMC12897663